Monika Lamba Saini
Director, Medical, Translational, & Computational Pathology GlaxoSmithKline
Dr Monika Lamba Saini, MBBS, MD, PhD, is the Director of Medical, Translational, and Computational Pathology at GSK, where she integrates pathology insights and AI technology into drug development through collaboration with multidisciplinary teams. She is also on the Education Committee of the Digital Pathology Association. Previously, she led Global Translational Pathology at ADC Therapeutics, advancing research strategies using digital pathology and AI. At IQVIA Laboratories, she directed Digital Pathology Innovation, overseeing system validation and AI support. With over 20 years of experience in pathology, she has served as a principal investigator on oncology trials with Cell Carta Belgium. She has extensive global experience and is the author and reviewer for notable journals and an invited speaker at international platforms.
Seminars
- Applying digital pathology and AI-driven image analysis to generate deeper insights into tumour biology, therapeutic response, and biomarker expression
- Integrating pathology, imaging, and translational datasets to improve confidence in development decisions and patient stratification strategies
- Understanding how computational pathology can accelerate biomarker discovery and support more predictive oncology research
- Which data sources provide the greatest opportunity to improve prediction of patient outcomes: pathology, imaging, clinical, biomarker, or multi-omic data?
- How can digital pathology, digital twins, and computational approaches be integrated with traditional tumour models to strengthen translational confidence?
- What evidence is needed before organisations can trust AI-generated insights to influence development and progression decisions?
- Audience Q&As
